Drug Development Pipeline
Inhaled Nitric Oxide (Thiolanox®)
Nitric oxide is a gas molecule produced by the body that plays a key role in the immune system. Nitric oxide has been shown to kill bacteria and break down their biofilms -- protective layers formed by bacteria that make them more difficult to eliminate. Researchers believe that increasing levels of nitric oxide in the body could help eliminate bacteria and increase lung function in people with CF.
A phase 2 study to test the safety and effectiveness of inhaled nitric oxide in adults with CF has been completed.
This program is sponsored by Novoteris and partially funded by the Cystic Fibrosis Foundation. It is being conducted within the Therapeutics Development Network.
Recent Inhaled Nitric Oxide (Thiolanox®) Studies
Closed to Enrollment
Phase 2 study of inhaled nitric oxide in people with CF (Novoteris NO-CF-02E)
Sign up for clinical trial alerts
Get email updates about clinical trials that matter to you.
Explore clinical trials
Be a part of the movement transforming the future of cystic fibrosis treatment.Learn More